Quest Diagnostics Inc. stock underperforms Friday when compared to competitors
Shares of Quest Diagnostics Inc. DGX shed 1.45% to $151.79 Friday, on what proved to be an all-around dismal trading session ...
News Medical on MSN12h
Menarini Group signs licensing deal with Insilico for promising cancer treatment
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused ...
MarketWatch19h
Palo Alto Networks Inc.
Cisco Systems Inc.-0.15% $234.07B ...